You're not very bright are you! I tell you precisely what I'm waiting for and you still don't know why I hang around. Perhaps you would be better served trying to expand your mind instead of learning four-letter words. I certainly hope you are a kid or else your development is hopelessly behind schedule. Anyway, I'm obviously wasting my time with u.
I've been waiting for the right price but it scares me when you have either paid pumpers working the boards or folks who have very little understanding also trying to push up the stock with nonsense. The warrants are extraordinarily illiquid and the bid/ask spread extremely wide, so the huge premium tells you almost nothing. (The only value of the warrant price, in my opinion, is it gives you some sense of what the latest buyers of the units paid for the stock itself.) Moreover, since they still have four years till expiration, they tell you nothing about the short term. Stocks like NWBO are purely speculative so the notion of predicting where the stock is going near-term is complete garbage. That doesn't mean you should stay away, but you should try to pay as little as possible to minimize the loss if it goes to zero.
The company has to do what it has to do.... And based on that, I do what I think circumstances dictate. Who is complaining, I'm simply stating my position that I would prefer to pay about what oppenheimers clients did, rather than 20% more. What exactly is the problem with that?
What do you disagree with? The buyers of the units could sell at $4.80, get their entire investment out, and still have substantial exposure to the stock, with zero risk. There is nothing to support price near $4.80
You're forgetting about the warrants. The $5 warrants are around $3 so the $6 warrants are probably worth at least $0.80. This means the stock was sold for about $4.00. I want to buy nwbo but will wait until it drops far closer to $4. I refuse to pay some 20% more that oppenheimer's clients.
I wasn't aware of imuc and nwbo until fairly recently. I've pulled the trigger on imuc but am having trouble doing so with nwbo, despite getting some good info from some posters, most notably red baron. What makes me most uneasy is the regular issuance of stock and warrants, invariably at a huge disadvantage to existing shareholders. The latest sale, for instance, allowed oppenheimers clients to essentially buy the stock for around $4 each, giving effect to the warrants. Those buyers could sell the stock now, make a small profit, and still have five-year warrants. For all intents and purposes, they got the long-term warrants free, at current stockholders expense. All the financings also complicate the task of figuring out the fully diluted number of shares outstanding.
Doing my dd before possibly buying on Monday. Any thoughts on why company can't find a company to partner a phase 3 trial for prostate when the potential market is so large and the money necessary is relative small... Around $70 million. Keep in mind FDA gave approval some six years ago.
All good points, thank you. With the 2012 warrants trading at $3.50, it will be interesting to see how the new warrants will be priced. Do you know if there will be any public trading of the warrants?
Thanks for the details red baron. A superficial review suggests the stock could do well long term, and I'll probably take a position at some point. I find the pricing, of both the stock and 2012 warrants, a little disconcerting, though. I don't understand why anyone would pay $3.50 for warrants with a conversion price of $5 when he could buy the stock for less than $5. I also don't understand why anyone would pay around $5 for a stock when others will be paying just $4.80 for the stock plus a five-year warrant.
Could you explain why you would pay roughly $4.80 a SHARE now when folks will be paying $4.80 a UNIT next Monday. The unit includes a share and a warrant that will probably be worth around 80 cents.
Last years offering was for 3 million shares and 1.5 million warrants. Are the warrants good for .5 share or 1.0 share? The new warrants are for .5 share. The 2012 warrants seem awfully expensive, even assuming they are for one full share. I would rather pay around $5 a share than $3 for the warrants. Would appreciate your thoughts; not many folks play with warrants so difficult to get well-informed opinions.
Your point being? The investors buying in next Monday's offering will effectively be paying roughly $4 a share for NWBO, factoring in the attached warrant, which should be valued at least 80 cents. If anybody disagrees with this assessment, please explain where I'm wrong. I'm not saying I think the stock is expensive, I'm saying the offering says the stock is now worth about $4.
Offering is expected to close on the 26th, so either 26th or 27th. Don't know what the symbol is going to be. I was hoping to buy the units but neither of my two brokers will be participating in the offering, unfortunately.
Don't really care, but don't understand the thumbs down. I'm simply assessing the facts, based on the details of the offering.
Just as a quick follow-up, the stock could clearly rebound, but the offering's pricing allows a short to lock in significant profits.
Based on the premiums for the July 2014 call options, the warrants should be worth a minimum of 45 cents. Since the duration is more than 50 months longer, I figure the warrants are worth at least 80 cents. So, if the units sell for $4.80, then the stock is being sold for about $4.00. I don't know much about the company, I'm thinking about possibly buying the warrants, but I definitely wouldn't buy the stock at $5.